APIs & Bulk Drugs Supplier in South Korea

The APIs and bulk drugs division supplies active pharmaceutical ingredients across major therapeutic classes, including anti-infectives, cardiovascular, antidiabetic, analgesic, gastrointestinal and CNS molecules. India is one of the world's largest API producing countries, and we source from manufacturers in established clusters such as Hyderabad, Vizag, Gujarat and Maharashtra.

Materials are offered to IP, BP, USP or Ph. Eur. monographs, or to in-house specifications where no monograph exists. Every shipment carries the manufacturer's batch COA and a GHS SDS. Depending on the product and the producing site, supporting documents such as a DMF letter of access, CEP, GMP certificate, EU written confirmation, TSE/BSE and residual solvent statements may be available. Availability is confirmed per product before you order, never assumed. We also help buyers assemble sample quantities for pre-qualification testing before a commercial order is placed.

Formulation manufacturers, generic companies developing dossiers, compounding and veterinary producers, and research groups needing reference quantities are the main buyers. Import of APIs is regulated in almost every market, so importers should confirm local licence, registration and site-approval requirements. We provide documents in the format the buyer's regulatory team requests where the manufacturer allows it.